Sign Out
Pazopanib doses up to 2000 mg have been evaluated in clinical studies. Grade 3 fatigue (dose-limiting toxicity) and Grade 3 hypertension were each observed in 1 of 3 patients dosed at 2000 mg and 1000 mg daily, respectively.
There is no specific antidote for overdose with pazopanib and treatment of overdose should consist of general supportive measures.
